Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
24%

OVERLAP
BY WEIGHT
39

# OF OVERLAPPING
HOLDINGS
SBIO
84
HOLDINGS
46%
ALSO IN XBI
XBI
137
HOLDINGS
28%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus XBI)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in SBIO
Weight
in XBI
Overlap
ORUKA THERAPEUTICS INC 3.1% 1.3% 1.3%
DIANTHUS THERAPEUTICS INC 3.3% 1.3% 1.3%
TRAVERE THERAPEUTICS, INC. 3.4% 1.3% 1.3%
CG ONCOLOGY, INC. 3.7% 1.3% 1.3%
RELAY THERAPEUTICS, INC. 2.3% 1.1% 1.1%
SBIO Overweight Relative to XBI
EDGEWISE THERAPEUTICS, INC. 2.6%
CG ONCOLOGY, INC. 2.4%
DEFINIUM THERAPEUTICS INC 2.3%
VERADERMICS INC 2.3%
TARSUS PHARMACEUTICALS, INC. 2.2%
AMYLYX PHARMACEUTICALS, INC. 2.1%
TRAVERE THERAPEUTICS, INC. 2.1%
DIANTHUS THERAPEUTICS INC 2.0%
ORUKA THERAPEUTICS INC 1.8%
NEWAMSTERDAM PHARMA CO NV 1.6%
SBIO Underweight Relative to XBI
MODERNA, INC. -2.9%
TWIST BIOSCIENCE CORP. -1.7%
HALOZYME THERAPEUTICS INC -1.4%
NATERA INC -1.4%
KYMERA THERAPEUTICS, INC. -1.4%
REVOLUTION MEDICINES, INC. -1.3%
PROTAGONIST THERAPEUTICS, INC. -1.3%
REGENERON PHARMACEUTICALS -1.3%
INSMED INC -1.3%
VAXCYTE, INC. -1.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY